Ligand validation:8CAI

HY0: HYGROMYCIN B VARIANT

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
3TYK_HY0_A_342	92%	35%	0.074	0.972	0.93	1.5	2	7	0	0	100%	1
3W0O_HY0_A_402	90%	25%	0.088	0.979	1.55	1.41	6	7	0	0	100%	1
3W0N_HY0_A_402	88%	27%	0.091	0.971	1.16	1.65	2	7	0	0	100%	1
3W0R_HY0_A_402	86%	33%	0.101	0.976	1.13	1.42	4	7	0	0	100%	1
4XCB_HY0_B_303	85%	35%	0.087	0.958	1.37	1.09	4	4	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729. RCSB PDB uses resources of the National Energy Research Scientific Computing Center (NERSC), a Department of Energy User Facility.